Pancreatic Cancer Research

ResearcherLeipzig UniversityNo recent work listed

Achim Michael Aigner

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2778-6256; OpenAlex author ID A5077066668. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper

Papers 2

  1. Integrin alpha-V is an important driver in pancreatic adenocarcinoma progression. Co-author DOI 10.1186/s13046-021-01946-2↗
  2. Silencing of Neuropilins and GIPC1 in pancreatic ductal adenocarcinoma exerts multiple cellular and molecular antitumor effects. Last author DOI 10.1038/s41598-019-51881-8↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hannes Borchardt · 1 shared paper, 2019 · strength 0.12
  2. Michael H. Muders · 1 shared paper, 2019 · strength 0.12
  3. Florian Gebauer · 1 shared paper, 2021 · strength 0.11
  4. Michael Tachezy · 1 shared paper, 2021 · strength 0.11
  5. Daniel Wicklein · 1 shared paper, 2021 · strength 0.11
  6. Udo Schumacher · 1 shared paper, 2021 · strength 0.11
  7. Marius Kemper · 1 shared paper, 2021 · strength 0.11
  8. Jakob Robert Izbicki · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.